Tonix Pharmaceuticals Holding (TNXP) Operating Margin (QoQ) (2022 - 2026)

Tonix Pharmaceuticals Holding (TNXP) Operating Margin (QoQ) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Tonix Pharmaceuticals Holding 142.07 Mn 142.07 Mn 5.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 29,193.00
Dec 31, 2025 10,923.00
Sep 30, 2025 41,114.00
Jun 30, 2025 -75,529.00
Mar 31, 2025 20,971.00
Dec 31, 2024 -31,947.00
Sep 30, 2024 295,046.00
Jun 30, 2024 -264,140.00
Mar 31, 2024 -13,705.00
Dec 31, 2023 -1,757.00
Sep 30, 2023 11,273.00
Sep 30, 2022 -32,122.00